grade
pharmaceutical primary standard
agency
USP
API family
betamethasone
manufacturer/tradename
USP
application(s)
pharmaceutical
format
mixture
storage temp.
2-8°C
General description
Application
Analysis Note
Other Notes
1 of 1
当該品目 | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard |
| manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP |
| format mixture | format neat | format mixture | format neat |
| application(s) pharmaceutical | application(s) pharmaceutical | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecules) |
| agency USP | agency USP | agency USP | agency USP |
| API family betamethasone | API family everolimus | API family carvedilol | API family nilotinib |
signalword
Danger
hcodes
Hazard Classifications
Repr. 1B - STOT RE 2
保管分類
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 2
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
1069095-15MG:
jan


